Literature DB >> 15117645

[Clinical significance of increased serum ferritin levels].

Carmen Ramírez1, Carmen Rubio, Rafael Angel Fernández de la Puebla, Cristóbal Aguilera, Isabel Espejo, Francisco Fuentes.   

Abstract

BACKGROUND AND
OBJECTIVE: We aimed to determine the diagnostic alternatives indicated by serum ferritin levels (2000 ng/ml, and to establish the clinical processes associated with very high levels (5000-10 000 ng/ml). PATIENTS AND
METHOD: We retrospectively analyzed cases with serum levels of ferritin serum equal to or greater than 2000 ng/ml between March 2000 and November 2001. Data were obtained from the laboratory's computerized database. Patients' medical records were reviewed by means of a protocol which established the clinical conditions associated with these serum ferritin values.
RESULTS: The study involved 135 patients with ferritin levels equal to or greater than 2000 ng/ml. Clinical syndromes included hematological diseases (45.9%), liver diseases (23%), chronic renal failure (17.78%), neoplastic diseases (10.4%), systemic inflammatory diseases (7.4%), chronic transfusions (7.4%), and non-HIV systemic infections (5.9%). Syndromes which are not usually associated with extreme serum ferritin levels were identified in 3.7% of the patients. The highest concentrations were seen in the systemic inflammatory disease group: 5856 (2492) ng/ml. Within this group, four patients with adult onset Still's disease (AOSD) displayed the highest mean ferritin levels: 11 322 (5474) ng/ml.
CONCLUSIONS: Elevated serum ferritin levels act as a non-specific marker for a large number of disorders. In certain inflammatory diseases such as adult onset Still's disease (AOSD), this finding may be an important tool.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15117645     DOI: 10.1016/s0025-7753(04)74296-7

Source DB:  PubMed          Journal:  Med Clin (Barc)        ISSN: 0025-7753            Impact factor:   1.725


  2 in total

1.  Serum ferritin and nutritional status in older adults at eldercare facilities.

Authors:  R Velasco-Rodriguez; M G Perez-Hernandez; A B Mora-Brambila; D A Bazan-Arellano; C Vasquez
Journal:  J Nutr Health Aging       Date:  2012       Impact factor: 4.075

2.  Successful treatment of interstitial pneumonitis with anakinra in a patient with adult-onset Still's disease.

Authors:  Irene Sollano-Sancho; Beatriz Rubio-Cebrian; Maria Luisa de la Cruz; Blanca San-Jose-Montano
Journal:  Eur J Hosp Pharm       Date:  2020-08-11
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.